Compound Detail
CHEMBL4282105
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4282105 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FTVZKYFNHVWEKW-AATRIKPKSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
421.4
MW (Da)
3.63
ALogP
8
HBA
0
HBD
92.5
PSA (Ų)
0.38
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 4.23
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| PC-3 | IC50 | = | 59220.0 | nM | 4.23 | Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay | 30108729 |
| HCT-116 | IC50 | = | 78900.0 | nM | 4.1 | Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay | 30108729 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30108729 | 10.1039/C7MD00267J | PC-3 | 1 |
| 30108729 | 10.1039/C7MD00267J | MCF7 | 1 |
| 30108729 | 10.1039/C7MD00267J | HCT-116 | 1 |
Data from ChEMBL 36 via Core Engine